In the current study, we confirmed that the percentage of patients expressing SCP3 in cervical cancer was relatively high (61.4% of all cases), and was significantly associated with the progression of cervical carcinogenesis from low-grade CIN to high-grade CIN to cancer (Table S1, P<0.001). Here, SYCP3 is linked to cervical carcinoma.